Core Viewpoint - IM Cannabis Corp. (IMC) is strategically entering the defense and homeland security technology sectors by signing a non-binding letter of intent to acquire 51% of Blackaxe Technologies, a Polish company specializing in advanced defense and intelligence solutions [1][2]. Company Overview - IMC is a medical cannabis company operating in Israel and Germany, currently focused on expanding into technology-driven sectors [6]. - The company operates a medical cannabis platform that serves patients in Israel and Germany, leveraging proprietary data and patient insights [7]. Acquisition Details - The proposed acquisition of Blackaxe Technologies represents a significant strategic expansion for IMC into the defense sector, particularly in areas such as satellite intelligence, AI analytics, and counter-drone solutions [2][3]. - Blackaxe operates using advanced Israeli technologies aimed at supporting governments and defense organizations in addressing aerial and intelligence threats [3]. Market Context - The transaction is set against a backdrop of a rapidly expanding global defense and security market, driven by rising geopolitical tensions and new threats, including low-cost drones and advanced missile systems [4]. - Current conflicts in Eastern Europe and the Middle East have increased demand for satellite intelligence and counter-drone technologies, which are critical for military and homeland security agencies [4]. Transaction Conditions - The proposed transaction is subject to due diligence, execution of definitive agreements, customary closing conditions, and regulatory approvals [5].